India may soon get its first dengue vaccine, Qdenga by Takeda, approved as safe and effective. This tetravalent vaccine protects against all four dengue strains and works without pre-screening. Planned for ages 4-60, it offers up to 64% efficacy. With rising dengue cases, it could significantly reduce severe infections and hospitalisations.